The preferential mobilisation of CD16+ NK-cells and monocytes is consistent with previous findings in CLL where a 254% increase in CD3−CD56+CD16+ NK-cells, and a 147% increase in non-classical monocytes was observed after a similar exercise protocol (Collier-Bain et al., 2024a). The gene discussed is FCGR3B; the disease is B-cell chronic lymphocytic leukemia.